deferiprone has been researched along with Deafness, Transitory in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirteen patients (35." | 1.39 | Audiologic and vestibular assessment in patients with β-thalassemia major receiving long-term transfusion therapy. ( Chao, YH; Lin, CD; Lin, CY; Peng, CT; Tsai, MH; Wu, HP; Wu, KH, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, YH | 1 |
| Wu, KH | 1 |
| Lin, CY | 1 |
| Tsai, MH | 1 |
| Peng, CT | 1 |
| Wu, HP | 1 |
| Lin, CD | 1 |
1 other study available for deferiprone and Deafness, Transitory
| Article | Year |
|---|---|
Audiologic and vestibular assessment in patients with β-thalassemia major receiving long-term transfusion therapy.
Topics: Acoustic Impedance Tests; Adolescent; Adult; Audiometry, Pure-Tone; beta-Thalassemia; Blood Transfus | 2013 |